Netherlands-based health tech startup developing sound-based medical technology (and software tools) to empower clinicians at the point of care and to enhance remote consultations, Lapsi Health raised USD 3.5 million in an oversubscribed seed round. The seed round took place on January 10, 2023. Sahir Ali of Modi Ventures led the financing for the firm. Pre-Seed investors of the company, such as Vendash and Bolwork, joined in the funding. Besides new investors, Israeli-Ukrainian software development company BeKey, provided the funding.
Purpose of financing for Lapsi Health
With the latest financing from the oversubscribed seed round, Lapsi Health intends to continue its technology development.
It also seeks to acquire FDA certification. Besides, the company has plans to begin commercialization activities in the USA.
The company earlier raised USD 700K in a pre- seed round in March 2022. Moreover, it received a grant of USD 1 million from Eurostars.
What the company’s officials have to say
Jhonatan Bringas Dimitriades, CEO at Lapsi Health, said, “During the year, we released four generations of prototypes and two native applications. We have been able to validate our technology and showcase it in several venues worldwide and to several medical leaders. This helped us to secure the next step in the funding for our company, now with the goal of bringing our technology to the market during 2023”.
Jhonatan Bringas further added, “With his vast med-tech experience, we will be able to develop and iterate even faster.”
In addition, Advisory Board Member and co-Chair of the DTRA, Craig Lipset, said, “As a patient, all of my encounters with my primary care provider and my pulmonologist involve listening to my lungs. Lapsi Health brings that capability with confidence for remote care as well as remote clinical trials. The technology will improve patient experience and outcomes while supporting the new normal for healthcare and clinical research.”
Besides, Chief Medical Officer and co-Founder Diana van Stijn – a leading expert in digital therapeutics and paediatrics, said, Data-driven decisions are the next steps to improving healthcare, patient empowerment, and clinical intelligence and making clinical research more democratized. These are the ideals that inspired us to create Lapsi Health.”
About the company
In 2022, Founders Diana van Stijn, MD, Jhonatan Bringas Dimitriades, MD, Rodrigo Alvez, and Séamus Holohan launched the company. Lapsi Health is a Medical Technology company developing Digital Biomarkers from medical sound analytics.
For more extensive analysis and Market Intelligence reports, feel free to approach us.
We try our best to fact-check and bring well-researched as well as non-plagiarized content to you. Please let us know
if there are any discrepancies in any of our published stories,
-how we can improve,
-what stories you would like us to cover
–what information you are looking for, in the comments section below or through our contact form! We look forward to your feedback, and thank you for stopping by!
Next Article
 to empower clinicians at the point of care and to enhance remote consultations, Lapsi Health raised USD 3.5 million in an oversubscribed seed round.){kind=link}